Cambridge Healthtech Associates, (CHA) brings together leading biopharmaceutical experts, senior executives and top scientists to share their knowledge and perspectives at the pre-competitive level to improve the productivity of R&D, thus improving the development of safe and effective therapies for patients.

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

Drug Safety Executive Council (DSEC) is a private online community whose members include over 1700 biopharmaceutical industry leaders with the common objective of facilitating the development of better and safer medicines.

Insight Pharma Reports has developed and maintained a very impressive and loyal client base, including senior level executives, global competitive intelligence executives, librarians, information specialists, and research scientists.

Bio-IT World provides breaking news, analysis, and opinion on enabling technologies that drive biomedical research and drug development, with emphasis on predictive biology, drug discovery, informatics, personalized medicine, and clinical trials.